165 related articles for article (PubMed ID: 33469898)
1. RING-finger protein 5 promotes hepatocellular carcinoma progression and predicts poor prognosis.
Zhang Y; Li J; Chen H; Zhang C; You S; Zhao Y; Lin X; Yu Y; Fang F; Fang T; Wang X
Hum Cell; 2021 Mar; 34(2):530-538. PubMed ID: 33469898
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29.
Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H
Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939
[TBL] [Abstract][Full Text] [Related]
4. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of miR-3607 predicts prognosis of hepatocellular carcinoma and regulates tumor cell proliferation, migration and invasion.
Dou W; Yang M; Su Y; Xie R
Diagn Pathol; 2020 May; 15(1):54. PubMed ID: 32404179
[TBL] [Abstract][Full Text] [Related]
6. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
[TBL] [Abstract][Full Text] [Related]
7. Uridine-cytidine kinase 2 upregulation predicts poor prognosis of hepatocellular carcinoma and is associated with cancer aggressiveness.
Huang S; Li J; Tam NL; Sun C; Hou Y; Hughes B; Wang Z; Zhou Q; He X; Wu L
Mol Carcinog; 2019 Apr; 58(4):603-615. PubMed ID: 30556610
[TBL] [Abstract][Full Text] [Related]
8. Hornerin promotes tumor progression and is associated with poor prognosis in hepatocellular carcinoma.
Fu SJ; Shen SL; Li SQ; Hua YP; Hu WJ; Guo B; Peng BG
BMC Cancer; 2018 Aug; 18(1):815. PubMed ID: 30103712
[TBL] [Abstract][Full Text] [Related]
9. miR-425-5p Acts as a Molecular Marker and Promoted Proliferation, Migration by Targeting RNF11 in Hepatocellular Carcinoma.
Rao D; Guan S; Huang J; Chang Q; Duan S
Biomed Res Int; 2020; 2020():6530973. PubMed ID: 33123581
[TBL] [Abstract][Full Text] [Related]
10. TRIM26 functions as a novel tumor suppressor of hepatocellular carcinoma and its downregulation contributes to worse prognosis.
Wang Y; He D; Yang L; Wen B; Dai J; Zhang Q; Kang J; He W; Ding Q; He D
Biochem Biophys Res Commun; 2015 Jul; 463(3):458-65. PubMed ID: 26043685
[TBL] [Abstract][Full Text] [Related]
11. Knockdown of miR-299-5p inhibits the progression of hepatocellular carcinoma by targeting SIAH1.
Jiang X; Shen X
Bull Cancer; 2018 Oct; 105(10):873-883. PubMed ID: 30266288
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of the metastasis-associated gene MTA3 correlates with tumor progression and poor prognosis in hepatocellular carcinoma.
Wang C; Li G; Li J; Li J; Li T; Yu J; Qin C
J Gastroenterol Hepatol; 2017 Aug; 32(8):1525-1529. PubMed ID: 27992674
[TBL] [Abstract][Full Text] [Related]
13. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of castor zinc finger 1 predicts poor prognosis and facilitates hepatocellular carcinoma progression via MAPK/ERK signaling.
Wang JL; Yang MY; Xiao S; Sun B; Li YM; Yang LY
J Exp Clin Cancer Res; 2018 Mar; 37(1):45. PubMed ID: 29506567
[TBL] [Abstract][Full Text] [Related]
15. Up-regulation of BRCA1-associated RING Domain 1 Promotes Hepatocellular Carcinoma Progression by Targeting Akt Signaling.
Liao Y; Yuan S; Chen X; Zhu P; Li J; Qin L; Liao W
Sci Rep; 2017 Aug; 7(1):7649. PubMed ID: 28794477
[TBL] [Abstract][Full Text] [Related]
16. Oncogene PLCE1 may be a diagnostic biomarker and prognostic biomarker by influencing cell cycle, proliferation, migration, and invasion ability in hepatocellular carcinoma cell lines.
Wang XK; Liao XW; Yang CK; Liu ZQ; Han QF; Zhou X; Zhang LB; Deng T; Gong YZ; Huang JL; Huang R; Han CY; Yu TD; Su H; Ye XP; Peng T; Zhu GZ
J Cell Physiol; 2020 Oct; 235(10):7003-7017. PubMed ID: 32037547
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of THOC1 reduces the proliferation of hepatocellular carcinoma and increases the sensitivity to cisplatin.
Cai S; Bai Y; Wang H; Zhao Z; Ding X; Zhang H; Zhang X; Liu Y; Jia Y; Li Y; Chen S; Zhou H; Liu H; Yang C; Sun T
J Exp Clin Cancer Res; 2020 Jul; 39(1):135. PubMed ID: 32669125
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-27b exerts an oncogenic function by targeting Fbxw7 in human hepatocellular carcinoma.
Sun XF; Sun JP; Hou HT; Li K; Liu X; Ge QX
Tumour Biol; 2016 Nov; 37(11):15325-15332. PubMed ID: 27704356
[TBL] [Abstract][Full Text] [Related]
19. An essential role of RNF187 in Notch1 mediated metastasis of hepatocellular carcinoma.
Zhang L; Chen J; Yong J; Qiao L; Xu L; Liu C
J Exp Clin Cancer Res; 2019 Sep; 38(1):384. PubMed ID: 31477177
[TBL] [Abstract][Full Text] [Related]
20. Fbxw7 regulates hepatocellular carcinoma migration and invasion via Notch1 signaling pathway.
Wang X; Zhang J; Zhou L; Sun W; Zheng ZG; Lu P; Gao Y; Yang XS; Zhang ZC; Tao KS; Dou KF
Int J Oncol; 2015 Jul; 47(1):231-43. PubMed ID: 25955618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]